Identification of novel beta1 integrin binding sites in the type 1 and type 2 repeats of thrombospondin-1 - PubMed (original) (raw)

. 2004 Oct 1;279(40):41734-43.

doi: 10.1074/jbc.M406267200. Epub 2004 Aug 3.

Affiliations

• PMID: 15292271
• DOI: 10.1074/jbc.M406267200

Free article

Identification of novel beta1 integrin binding sites in the type 1 and type 2 repeats of thrombospondin-1

Maria J Calzada et al. J Biol Chem. 2004.

Free article

Abstract

In addition to the three known beta(1) integrin recognition sites in the N-module of thrombospondin-1 (TSP1), we found that beta(1) integrins mediate cell adhesion to the type 1 and type 2 repeats. The type 1 repeats of TSP1 differ from typical integrin ligands in that recognition is pan-beta(1)-specific. Adhesion of cells that express one dominant beta(1) integrin on immobilized type 1 repeats is specifically inhibited by antagonists of that integrin, whereas adhesion of cells that express several beta(1) integrins is partially inhibited by each alpha-subunit-specific antagonist and completely inhibited by combining the antagonists. beta(1) integrins recognize both the second and third type 1 repeats, and each type 1 repeat shows pan-beta(1) specificity and divalent cation dependence for promoting cell adhesion. Adhesion to the type 2 repeats is less sensitive to alpha-subunit antagonists, but a beta(1) blocking antibody and two disintegrins inhibit adhesion to immobilized type 2 repeats. beta(1) integrin expression is necessary for cell adhesion to the type 1 or type 2 repeats, and beta(1) integrins bind in a divalent cation-dependent manner to a type 1 repeat affinity column. The widely used TSP1 function blocking antibody A4.1 binds to a site in the third type 2 repeat. A4.1 proximally inhibits beta(1) integrin-dependent adhesion to the type 2 repeats and indirectly inhibits integrin-dependent adhesion mediated by the TSP1 type 1 repeats. Although antibody A4.1 is also an antagonist of CD36 binding to TSP1, these data suggest that some biological activities of A4.1 result from antagonism of these novel beta(1) integrin binding sites.

PubMed Disclaimer

Similar articles

• Identification of an alpha(3)beta(1) integrin recognition sequence in thrombospondin-1.
  Krutzsch HC, Choe BJ, Sipes JM, Guo Nh, Roberts DD. Krutzsch HC, et al. J Biol Chem. 1999 Aug 20;274(34):24080-6. doi: 10.1074/jbc.274.34.24080. J Biol Chem. 1999. PMID: 10446179
• Conformational regulation of the fibronectin binding and alpha 3beta 1 integrin-mediated adhesive activities of thrombospondin-1.
  Rodrigues RG, Guo N, Zhou L, Sipes JM, Williams SB, Templeton NS, Gralnick HR, Roberts DD. Rodrigues RG, et al. J Biol Chem. 2001 Jul 27;276(30):27913-22. doi: 10.1074/jbc.M009518200. Epub 2001 May 17. J Biol Chem. 2001. PMID: 11358957
• Interactions of thrombospondins with alpha4beta1 integrin and CD47 differentially modulate T cell behavior.
  Li Z, Calzada MJ, Sipes JM, Cashel JA, Krutzsch HC, Annis DS, Mosher DF, Roberts DD. Li Z, et al. J Cell Biol. 2002 Apr 29;157(3):509-19. doi: 10.1083/jcb.200109098. Epub 2002 Apr 29. J Cell Biol. 2002. PMID: 11980922 Free PMC article.
• Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms.
  Sweetwyne MT, Murphy-Ullrich JE. Sweetwyne MT, et al. Matrix Biol. 2012 Apr;31(3):178-86. doi: 10.1016/j.matbio.2012.01.006. Epub 2012 Jan 14. Matrix Biol. 2012. PMID: 22266026 Free PMC article. Review.

Cited by

• Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.
  Miller TW, Kaur S, Ivins-O'Keefe K, Roberts DD. Miller TW, et al. Matrix Biol. 2013 Aug 8;32(6):316-24. doi: 10.1016/j.matbio.2013.02.009. Epub 2013 Mar 13. Matrix Biol. 2013. PMID: 23499828 Free PMC article.
• Function-blocking antithrombospondin-1 monoclonal antibodies.
  Annis DS, Murphy-Ullrich JE, Mosher DF. Annis DS, et al. J Thromb Haemost. 2006 Feb;4(2):459-68. doi: 10.1111/j.1538-7836.2006.01723.x. J Thromb Haemost. 2006. PMID: 16420580 Free PMC article.
• Polymorphism in THBS1 gene is associated with post-refractive surgery chronic ocular surface inflammation.
  Contreras-Ruiz L, Ryan DS, Sia RK, Bower KS, Dartt DA, Masli S. Contreras-Ruiz L, et al. Ophthalmology. 2014 Jul;121(7):1389-97. doi: 10.1016/j.ophtha.2014.01.033. Epub 2014 Mar 27. Ophthalmology. 2014. PMID: 24679443 Free PMC article.
• The Endothelial Glycocalyx as a Target of Excess Soluble Fms-like Tyrosine Kinase-1.
  Schulz A, Drost CC, Hesse B, Beul K, Boeckel GR, Lukasz A, Pavenstädt H, Brand M, Di Marco GS. Schulz A, et al. Int J Mol Sci. 2023 Mar 11;24(6):5380. doi: 10.3390/ijms24065380. Int J Mol Sci. 2023. PMID: 36982455 Free PMC article.
• Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.
  Roberts DD, Kaur S, Isenberg JS. Roberts DD, et al. Antioxid Redox Signal. 2017 Oct 20;27(12):874-911. doi: 10.1089/ars.2017.7140. Epub 2017 Sep 8. Antioxid Redox Signal. 2017. PMID: 28712304 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal